<div class="table-responsive">
    <table class="table table-striped table-hover">
        <thead>
            <tr>
                
                <th scope="col">
                    <a href="?cresstrial=6691&amp;modal=1&amp;valnames=primary_outcome&amp;order=created_at">Created at</a>
                </th>
                <th scope="col">Source</th>
                
                <th scope="col">Raw Value</th>
                <th scope="col">Validated value</th>
            </tr>
        </thead>
        <tbody>
            
            <tr class="histvalue-row" histvalueid="142289" class="table-">
                
                <td>Oct. 5, 2021, 11 a.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="primary_outcome">
            Adverse events;Clinical laboratory tests: Clinically significant changes of hematology, clinical chemistry and coagulation assessed via blood sample collection;Clinical laboratory tests: Clinically significant changes of urinalysis measurement assessed via urin collection;Fractional Exhaled Nitric Oxide (FeNO) levels measured in parts per billion (ppb) - in MAD cohort only;Heart function: QT interval corrected for heart rate (QTc) (Bazett&#x27;s correction [QTcB]) in msec assessed via Twelve lead ECG;Physical examination: Abnormal findings of the cardiovascular system;Physical examination: Abnormal findings of the dermatologic system;Physical examination: Abnormal findings of the ears;Physical examination: Abnormal findings of the extremities;Physical examination: Abnormal findings of the eyes;Physical examination: Abnormal findings of the gastrointestinal system;Physical examination: Abnormal findings of the general appearance;Physical examination: Abnormal findings of the head;Physical examination: Abnormal findings of the lymph nodes;Physical examination: Abnormal findings of the mouth/throat/neck;Physical examination: Abnormal findings of the musculoskeletal system;Physical examination: Abnormal findings of the neurologic system;Physical examination: Abnormal findings of the nose;Physical examination: Abnormal findings of the psychiatric system;Physical examination: Abnormal findings of the respiratory system;Physical examination: Abnormal findings of the thyroid;Pulmonary function assessed via FEV1/FVC ratio measured in % by spirometry;Pulmonary function assessed via Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) measured in L by spirometry;Pulmonary function assessed via Peak expiratory flow (PEF) measured in L/s by spirometry;Pulmonary function assessed via Total lung capacity (TLC) and Residual volume (RV) measured in L by body plethysmography;Vital signs: Body temperature assessed contactless via TriTemp thermometer in degree C;Vital signs: Peripheral oxygen saturation (SaO2) measured in %;Vital signs: Respiratory rate measured in breaths/min;Vital signs: Resting pulse rate measured in beats per minute;Vital signs: Supine blood pressure assessed by systolic and diastolic blood pressure in mmHg
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="primary_outcome validated">
            Adverse events;Clinical laboratory tests: Clinically significant changes of hematology, clinical chemistry and coagulation assessed via blood sample collection;Clinical laboratory tests: Clinically significant changes of urinalysis measurement assessed via urin collection;Fractional Exhaled Nitric Oxide (FeNO) levels measured in parts per billion (ppb) - in MAD cohort only;Heart function: QT interval corrected for heart rate (QTc) (Bazett&#x27;s correction [QTcB]) in msec assessed via Twelve lead ECG;Physical examination: Abnormal findings of the cardiovascular system;Physical examination: Abnormal findings of the dermatologic system;Physical examination: Abnormal findings of the ears;Physical examination: Abnormal findings of the extremities;Physical examination: Abnormal findings of the eyes;Physical examination: Abnormal findings of the gastrointestinal system;Physical examination: Abnormal findings of the general appearance;Physical examination: Abnormal findings of the head;Physical examination: Abnormal findings of the lymph nodes;Physical examination: Abnormal findings of the mouth/throat/neck;Physical examination: Abnormal findings of the musculoskeletal system;Physical examination: Abnormal findings of the neurologic system;Physical examination: Abnormal findings of the nose;Physical examination: Abnormal findings of the psychiatric system;Physical examination: Abnormal findings of the respiratory system;Physical examination: Abnormal findings of the thyroid;Pulmonary function assessed via FEV1/FVC ratio measured in % by spirometry;Pulmonary function assessed via Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) measured in L by spirometry;Pulmonary function assessed via Peak expiratory flow (PEF) measured in L/s by spirometry;Pulmonary function assessed via Total lung capacity (TLC) and Residual volume (RV) measured in L by body plethysmography;Vital signs: Body temperature assessed contactless via TriTemp thermometer in degree C;Vital signs: Peripheral oxygen saturation (SaO2) measured in %;Vital signs: Respiratory rate measured in breaths/min;Vital signs: Resting pulse rate measured in beats per minute;Vital signs: Supine blood pressure assessed by systolic and diastolic blood pressure in mmHg
        </p>
        
    
                </td>
            </tr>
            
        </tbody>
    </table>
</div>